Europe

Tesla has started to offer lower-priced versions of its vehicles outside of the U.S.

The environmental, social, and governance label remains a selling point for European investors even as it has fallen out of favor in the U.S. It’s unclear whether these investments pay off because the category is loosely defined.

Cryptocurrencies have benefited from the notion of the “debasement trade,” where assets like Bitcoin and gold gain value as fiat currencies weaken.

Novo said it would buy Akero for $54 a share in cash and an additional $6 if it gets U.S. approval of efruxifermin, it’s treatment for fatty liver disease.

The Prancing Horse hit the brakes on its electric supercar plan—but that isn't what was dragging down shares.

The IMF’s Kristalina Georgieva sees “exceptionally high” uncertainly persisting. Here’s her advice for nations navigating tricky economies.

HSBC made the call as it listed the pharma stocks it sees as best positioned to play a recovery in the sector.

The Spotify founder will transition to executive chairman, with Gustav Söderström and Alex Norström taking over as co-CEOs.

USA Rare Earth rises after it announces plans to buy U.K.-based maker of rare earth alloys.

Apple stock has been driven by apparently healthy demand for the latest devices.

U.S. prescriptions for Novo's Ozempic and Wegovy drugs are stagnating, Morgan Stanley analysts said.

Genmab will acquire Merus in an all-cash transaction worth around $8 billion.

The blockbuster medications could open a new frontier for the pharma giants.

That growth is expected to continue this year as the U.S. stock market continues to trend higher

Trump’s threat of a 100% tariff on imported branded or patented drugs sounds dramatic, yet, pharma stocks were mostly in the green as the past few months have already seen a flurry of companies announcing plans to invest in the U.S.

Tesla stock closed above $442 on Wednesday. It was the stock’s highest close since Dec. 26, 2024, when shares closed at $454.13.

A cottage industry of lawyers, bankers, and accountants defrauded governments of at least $164 billion in the past few decades, tax authorities estimate.

Asset managers reported rising revenue and stubbornly sticky profit margins in 2024, but their business looks likely to change in the year ahead as alternative investing goes mainstream.

The countries say they will work together to ‘realize true quantum advantage’ and develop standards.

Friday, Goldman Sachs launched coverage of four European aerospace stocks with Buy ratings.

The European Union will ban the sale of new gasoline-powered internal-combustion passenger cars by 2035 in favor of EVs. Auto makers sense the opportunity.

The U.K. central bank is in a tough position, with inflation running way above its 2% target.

The plan is straight out of the Cold War playbook, Leslie Palti-Guzman writes in a guest commentary.

Clinical trial results that showed the treatment reduced cardiovascular death, heart attack and stroke by 14% compared with placebo.

IQM raised more than $300 million in a recent funding round, bringing the total raised to $600 million.